Navigation Links
New Insights on Elective Single Embryo Transfer from Nationwide IVF Patient Survey to be presented at the American Society for Reproductive Medicine
Date:10/16/2015

Progyny, the leading company dedicated to helping ensure patients control their fertility journey and achieve the best possible outcomes, announced today new insights on factors associated with increased likelihood of acceptance of elective single embryo transfer (eSET) for patients undergoing IVF from a nationwide IVF patient survey will be presented at the American Society for Reproductive Medicine (ASRM) in Baltimore, MD.

“Findings from this analysis provide some actionable recommendations on how we, as a community, can be doing more to help educate patients regarding the number of embryos to transfer,” stated Barbara Collura, President and CEO of RESOLVE: The National Infertility Association.  “Patients undergoing IVF want to become parents, and are faced with many decisions during their family building journey.  We can all do better to educate and inform those considering IVF on the risks of a multiple birth and what options are available to them.  And we know that lack of insurance coverage for this medical procedure can affect their decision making.”

The studies show that targeted education regarding risks of multiple gestation and benefits of eSET through multiple channels, earlier discussions on transfer order, and emphasizing the potential health risks to offspring are key areas of opportunity to influence a patient’s acceptance of single embryo transfer (SET).   In addition the study evaluated demographics and found patients living in the Midwest may be least likely to have eSET and may benefit most from increased education. 

Despite the data that demonstrates multiple pregnancy rates are associated with more adverse health outcomes to infants along with increased risk of pregnancy and birth complications(1), the practice of eSET is still underutilized.  Women who are electing single embryo transfer represent less than 9% of all IVF cycles.(2)  In addition there is also significant economic burden, recent published data has shown the healthcare costs (up to one year post birth) of twins to be 4 times, and triplets 18 times, more than the costs of a singleton birth.

“Our company puts the patient at the center of everything we do,” said Gina Bartasi, Chief Executive Officer, “therefore, we embrace these opportunities to better understand the patient perspective so that we can help provide relevant and meaningful programs to support patients undergoing IVF.”

The results are based on a nationwide IVF patient survey that was conducted by RESOLVE: The National Infertility Association and sponsored by Progyny.  Five abstract presentations will be presented by University of Iowa Hospitals who completed all the analysis. 

Full session details and data presentation listings for the 2015 meeting can be found on the ASRM website at http://www.asrmannualmeeting.org.

1-Practice Committee of American Society for Reproductive Medicine. Fertility and Sterility. April 2012.
2-SART.org (Society for Assisted Reproductive Technology, National Summary Report)

About Progyny: 
Progyny, the combined entity of Auxogyn, Inc. and Fertility Authority LLC, is the first company to provide fertility patients with easy accessibility to high quality doctors, price transparency, and financing, coupled with extraordinary clinical expertise and proprietary clinical solutions. Rooted in clinical excellence and serving as a champion for the consumer, the company is committed to helping ensure that patients control their fertility journey and achieve the best possible outcome. Progyny is privately held and its investors include Kleiner Perkins Caufield & Byers, TPG Biotech, SR One and Merck Serono Ventures. The company is headquartered in New York, NY, with operations in Menlo Park, CA. For more information, please visit http://www.progyny.com.

About RESOLVE: The National Infertility Association: 
Established in 1974, RESOLVE: The National Infertility Association is a non-profit organization with the only established, nationwide network mandated to promote reproductive health and to ensure equal access to all family building options for men and women experiencing infertility or other reproductive disorders. One in eight U.S. couples of childbearing age has trouble conceiving or carrying a pregnancy to term.  RESOLVE addresses this public health issue by providing community to these women and men, connecting them with others who can help, empowering them to find resolution and giving voice to their demands for access to all family building options.  For more information, visit http://www.RESOLVE.org.

Read the full story at http://www.prweb.com/releases/2015/10/prweb13026699.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved


Related biology technology :

1. Ingenuity Systems IPA Provides Researchers with Genomic Insights Suggesting that Physical Activity Does Not Slow Muscle Aging
2. BioInformatics LLC Announces New Market Report – Enhancing the Customer Experience: Insights and Life Science Supplier Rankings (13-002)
3. Risk-based Approach to Monitoring: Deployment Insights and Lessons Learned, New Xtalks Webinar
4. Mold Plagues New Florida Home Owners, Environmental Impact Assessment Company AGC Environmental Offers Them Insights on Obtaining Expert Mold Remediation and Inspection
5. Mom – the Ultimate Chromatographer: Insights into HPLC and GC Chromatography
6. FDA Review in Journal for ImmunoTherapy of Cancer Offers New Insights into Cancer Immunotherapy Product Development & Clinical Evaluation
7. Ganeden Partner Product Wins SupplySide Insights Award
8. Linguamatics Launches Healthcare Product Suite to Turn Unstructured Electronic Health Record Data into Actionable Patient Insights
9. Huntsman Cancer Institute Uses Linguamatics I2E to Automatically Extract Insights from Clinical Pathology Documents
10. Elsevier Launches the New Generation SciVal, Providing Dynamic Real-Time Analytics and Insights into the Global Research Landscape
11. New Insights on the Decline of Research and Development in Pharma & Biotech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2020)... MONTEREY, Calif. (PRWEB) , ... January 24, 2020 ... ... the launch of their RedySmart™ mass flow meters and controllers ideal ... as an ideal upgrade to antiquated rotameters. These thermal instruments employ high-precision ...
(Date:1/22/2020)... ... ... QCDx , a private biotech company that has developed a breakthrough Circulating ... of the proprietary RareScope™ instrument to the Carole and Ray Neag Comprehensive Cancer Center ... “The RareScope can detect and isolate intact and live Circulating Tumor Cells from a ...
(Date:1/8/2020)... Conn. (PRWEB) , ... January 08, 2020 , ... ... whose exceptional quality and care helps couples and individuals grow their family, has ... prestigious Top Doc award by Castle Connolly. Since 1991, the renowned publishing company ...
(Date:1/7/2020)... ... January 06, 2020 , ... ABCT , ... biosciences ventures invited to participate in the annual program. Twelve ventures will participate ... and a professional network. All startups will receive an entrepreneur coach, access to ...
Breaking Biology Technology:
(Date:2/6/2020)... ... February 06, 2020 , ... ... specializing in complex interventional medical device and pharmaceutical trials, announced that Ms. ... this newly established role, Dorothy oversees the development and execution of regulatory ...
(Date:1/30/2020)... ... January 30, 2020 , ... Accelera Canada , a full-service ... Canadian market, is pleased to announce that the company has opened the doors of ... launched in 2017. , “We are so thrilled to now have all our ...
(Date:1/28/2020)... ... January 28, 2020 , ... ... improve care efficiency, reduce total cost of care, and limit the utilization of ... healthcare provider group headquartered in San Antonio, Texas specializes in improving care delivery ...
Breaking Biology News(10 mins):